{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:37:08Z","timestamp":1762101428513},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00417-013-2375-7","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T01:58:28Z","timestamp":1369015108000},"page":"2705-2709","source":"Crossref","is-referenced-by-count":23,"title":["Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration"],"prefix":"10.1007","volume":"251","author":[{"given":"Monica","family":"Dalal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima","family":"Jacobs-El","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsheng","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chao","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Meyerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"issue":"9652","key":"2375_CR1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(08)61759-6","volume":"372","author":"HR Coleman","year":"2008","unstructured":"Coleman HR, Chan CC, Ferris FL III, Chew EY (2008) Age-related macular degeneration. Lancet 372(9652):1835\u20131845","journal-title":"Lancet"},{"issue":"6","key":"2375_CR2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archophthalmol.2010.92","volume":"128","author":"R Klein","year":"2010","unstructured":"Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, Huang GH, Pankow JS, Klein BE (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128(6):750\u2013758","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2375_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajo.2007.06.025","volume":"144","author":"RB Nussenblatt","year":"2007","unstructured":"Nussenblatt RB, Ferris F III (2007) Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 144(4):618\u2013626","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2375_CR4","first-page":"432","volume":"10","author":"RB Nussenblatt","year":"2009","unstructured":"Nussenblatt RB, Liu B, Li Z (2009) Age-related macular degeneration: an immunologically driven disease. Curr Opin Investig Drugs 10(5):432\u2013442","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"2375_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-008-0112-9","volume":"30","author":"M Patel","year":"2008","unstructured":"Patel M, Chan CC (2008) Immunopathological aspects of age-related macular degeneration. Semin Immunopathol 30(2):97\u2013110","journal-title":"Semin Immunopathol"},{"key":"2375_CR6","first-page":"184","volume":"16","author":"B Liu","year":"2010","unstructured":"Liu B, Faia L, Hu M, Nussenblatt RB (2010) Pro-angiogenic effect of IFNgamma is dependent on the PI3K\/mTOR\/translational pathway in human retinal pigment epithelial cells. Mol Vis 16:184\u2013193","journal-title":"Mol Vis"},{"issue":"2","key":"2375_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/eye.2010.196","volume":"25","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wang VM, Chan CC (2011) The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) 25(2):127\u2013139","journal-title":"Eye (Lond)"},{"issue":"4","key":"2375_CR8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"V Tarallo","year":"2012","unstructured":"Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, Cho WG, Kaneko H, Fowler BJ, Bogdanovich S, Albuquerque RJ, Hauswirth WW, Chiodo VA, Kugel JF, Goodrich JA, Ponicsan SL, Chaudhuri G, Murphy MP, Dunaief JL, Ambati BK, Ogura Y, Yoo JW, Lee DK, Provost P, Hinton DR, Nu\u00f1ez G, Baffi JZ, Kleinman ME, Ambati J (2012) DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149(4):847\u2013859","journal-title":"Cell"},{"issue":"5","key":"2375_CR9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm.2717","volume":"18","author":"SL Doyle","year":"2012","unstructured":"Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF, Farrar GJ, Kiang AS, Humphries MM, Layelle EC, O\u2019Neill LA, Hollyfield JG, Humphries P (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 18(5):791\u2013798","journal-title":"Nat Med"},{"issue":"8","key":"2375_CR10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMcibr1204973","volume":"367","author":"JT Rosenbaum","year":"2012","unstructured":"Rosenbaum JT (2012) Eyeing macular degeneration\u2014a few inflammatory remarks. N Engl J Med 367(8):768\u2013770","journal-title":"N Engl J Med"},{"issue":"2","key":"2375_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nm.2091","volume":"16","author":"MR Janes","year":"2010","unstructured":"Janes MR, Limon JJ, So L, Chen J, Lim RJ, Chavez MA, Vu C, Lilly MB, Mallya S, Ong ST, Konopleva M, Martin MB, Ren P, Liu Y, Rommel C, Fruman DA (2010) Effective and selective targeting of leukemia cells using a TORC1\/2 kinase inhibitor. Nat Med 16(2):205\u2013213","journal-title":"Nat Med"},{"issue":"23","key":"2375_CR12","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4161\/cc.8.23.10070","volume":"8","author":"B Shor","year":"2009","unstructured":"Shor B, Gibbons JJ, Abraham RT, Yu K (2009) Targeting mTOR globally in cancer: thinking beyond rapamycin. Cell Cycle 8(23):3831\u20133837","journal-title":"Cell Cycle"},{"issue":"22","key":"2375_CR13","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1158\/0008-5472.CAN-08-2058","volume":"68","author":"Q Xue","year":"2008","unstructured":"Xue Q, Hopkins B, Perruzzi C, Udayakumar D, Sherris D, Benjamin LE (2008) Palomid 529, a novel small-molecule drug, is a TORC1\/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability. Cancer Res 68(22):9551\u20139557","journal-title":"Cancer Res"},{"issue":"8","key":"2375_CR14","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI24726","volume":"115","author":"E Ackah","year":"2005","unstructured":"Ackah E, Yu J, Zoellner S, Iwakiri Y, Shurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, Walsh K, Sessa WC (2005) Akt1\/protein kinase B\u03b1 is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 115(8):2119\u20132127","journal-title":"J Clin Invest"},{"issue":"6736","key":"2375_CR15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/21218","volume":"399","author":"D Fulton","year":"1999","unstructured":"Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399(6736):597\u2013601","journal-title":"Nature"},{"issue":"8","key":"2375_CR16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1096\/fj.01-0658com","volume":"16","author":"R Humar","year":"2002","unstructured":"Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ (2002) Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamcyin (mTOR)-dependent signaling. FASEB J 16(8):771\u2013780","journal-title":"FASEB J"},{"key":"2375_CR17","first-page":"964","volume":"10","author":"N Dejneka","year":"2004","unstructured":"Dejneka N, Kuroki AM, Fosnot J, Tang W, Tolentino MJ, Bennett J (2004) Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis 10:964\u2013972","journal-title":"Mol Vis"},{"key":"2375_CR18","unstructured":"Paloma Pharmaceuticals, Inc (2009) Palomid 529 investigator\u2019s brochure (3rd ed.) [Brochure]"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2375-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2375-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2375-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:48:27Z","timestamp":1559058507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2375-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2375-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}